Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been assigned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $11.0625.

A number of equities analysts have recently issued reports on AVAH shares. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Barclays increased their price target on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. Raymond James Financial reissued an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a research report on Friday, December 5th. Finally, Royal Bank Of Canada upped their target price on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a report on Thursday, January 15th.

Insider Activity

In other news, insider Patrick A. Cunningham sold 18,436 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $132,923.56. Following the sale, the insider owned 337,755 shares of the company’s stock, valued at $2,435,213.55. The trade was a 5.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Edwin C. Reisz sold 60,769 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $438,144.49. Following the transaction, the insider owned 1,447,057 shares in the company, valued at approximately $10,433,280.97. This trade represents a 4.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 998,595 shares of company stock valued at $7,567,770. Company insiders own 7.00% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently modified their holdings of the business. Caitong International Asset Management Co. Ltd grew its holdings in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter worth $43,000. Lion Street Advisors LLC acquired a new position in shares of Aveanna Healthcare during the 3rd quarter worth $89,000. EverSource Wealth Advisors LLC grew its stake in shares of Aveanna Healthcare by 88,100.0% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after purchasing an additional 11,453 shares during the period. Finally, State of Alaska Department of Revenue purchased a new position in shares of Aveanna Healthcare in the 3rd quarter valued at about $106,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Trading Down 0.4%

NASDAQ:AVAH opened at $7.23 on Monday. The company has a market capitalization of $1.51 billion, a PE ratio of 20.08 and a beta of 2.07. Aveanna Healthcare has a 52-week low of $3.67 and a 52-week high of $10.32. The stock’s 50 day moving average price is $8.14 and its 200 day moving average price is $8.56. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.